Related Experiment Videos

Expression of growth factor-toxin fusion proteins

G M Edwards¹, D Defeo-Jones, S M Stirdivant

¹Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania.

Targeted Diagnosis and Therapy

|January 1, 1992

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Synchronous renal malignancy presenting as recurrent urinary tract infections.

Case reports in urology·2012

Farnesyl:protein transferase inhibitors as potential agents for the management of human prostate cancer.

Prostate cancer and prostatic diseases·2002

Evaluation of farnesyl:protein transferase and geranylgeranyl:protein transferase inhibitor combinations in preclinical models.

Cancer research·2001

The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy.

Journal of medicinal chemistry·2001

Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency.

Journal of medicinal chemistry·2001

Signaling pathways in apoptosis as potential targets for cancer therapy.

Trends in cell biology·2001

See all related articles